Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Second Randomized Controlled Trial of Alternating Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip or Knee

NCT05607030 is registered in ClinicalTrials.gov with Osteal Therapeutics, Inc. as lead sponsor.

NCT NCT05607030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05607030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Second Randomized Controlled Trial of Alternating Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip or Knee
Lead sponsor
Osteal Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 23, 2023
Completion date
October 30, 2024
Enrollment
76 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

prosthetic-joint infection